Sperm banking before gonadotoxic treatment: is it worth the effort?

Author: Kilian VOMSTEIN ¹ ; Elisabeth REISER ¹ ; Germar M PINGGERA ² ; Peter TOERZSOEK ³ ; Susanne DEININGER ³ ; Thomas KRIESCHE ¹ ; Wolfgang BIASIO ¹ ; Lukas LUSUARDI ³ ; Bettina TOTH ¹
Author Information

1. Department of Gynecological Endocrinology and Reproductive Medicine, Medical University Innsbruck, Innsbruck 6020, Austria.
2. Department of Urology, Medical University Innsbruck, Innsbruck 6020, Austria.
3. Department of Urology and Andrology, University Hospital of Salzburg, Salzburg 5020, Austria.
Publication Type:Journal Article
Keywords: cryopreservation; fertility; gonadotoxic treatment; sperm count; testicular disease
From: Asian Journal of Andrology 2021;23(5):490-494
CountryChina
Language:English
Abstract: We aimed to compare the sperm quality in different cancer types and benign diseases before gonadotoxic treatment, and assess the usage rate of cryopreserved sperm for assisted reproductive treatment (ART). This retrospective study was conducted at two university clinics between January 2008 and July 2018. A total of 545 patients suffering from cancer or benign diseases were included in the study. The pretreatment sperm analyses were based on the World Health Organization (WHO) guidelines. Patients with testicular malignancy (TM) showed a significantly lower sperm count (median [interquartile range]: 18.7 × 10